Literature DB >> 23999974

Drug adherence in patients taking oral anticoagulation therapy.

Sebastian Ewen1, Volker Rettig-Ewen, Felix Mahfoud, Michael Böhm, Ulrich Laufs.   

Abstract

Oral anticoagulation has proven to reduce mortality and morbidity of thromboembolic events. One of the most important determinants of the effectiveness and safety of anticoagulation therapy is the adherence to the prescribed therapy. Vitamin K antagonists are characterized by under-utilization, a narrow therapeutic window and multiple food and drug interactions which contribute to a variable dose-response relationship with the risk of insufficient protection and/or increased bleeding risk. The "new" direct oral anticoagulants have demonstrated equal or superior protection and reduced bleeding risks compared to warfarin and are easier to use because of fixed dosing without monitoring of anticoagulation. Controlling of adherence to the direct oral anticoagulants is difficult. Therefore, continuous and regular medication intake represents a pre-requisite for achieving optimal protection. The present review aims to give an overview about the factors that affect drug adherence in patients taking oral anticoagulation drugs and discusses strategies to improve drug adherence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23999974     DOI: 10.1007/s00392-013-0616-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  90 in total

1.  Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation.

Authors:  T Michelle Brown; Kimberly Siu; David Walker; Manel Pladevall-Vila; Stephen Sander; Margaret Mordin
Journal:  J Manag Care Pharm       Date:  2012-06

Review 2.  A meta-analysis of the association between adherence to drug therapy and mortality.

Authors:  Scot H Simpson; Dean T Eurich; Sumit R Majumdar; Rajdeep S Padwal; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2006-06-21

3.  Impact of medication adherence on hospitalization risk and healthcare cost.

Authors:  Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

4.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

5.  Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.

Authors:  Stuart J Connolly; Janice Pogue; John Eikelboom; Gregory Flaker; Patrick Commerford; Maria Grazia Franzosi; Jeffrey S Healey; Salim Yusuf
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

6.  The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.

Authors:  Illkyu-O Lee; Mario T Kratz; Stephan H Schirmer; Magnus Baumhäkel; Michael Böhm
Journal:  J Pharmacol Exp Ther       Date:  2012-07-25       Impact factor: 4.030

Review 7.  Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.

Authors:  T Steiner; M Böhm; M Dichgans; H-C Diener; C Ell; M Endres; C Epple; M Grond; U Laufs; G Nickenig; H Riess; J Röther; P D Schellinger; M Spannagl; R Veltkamp
Journal:  Clin Res Cardiol       Date:  2013-05-14       Impact factor: 5.460

Review 8.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

9.  Randomized controlled trial on cardiovascular risk management by practice nurses supported by self-monitoring in primary care.

Authors:  Ans H Tiessen; Andries J Smit; Jan Broer; Klaas H Groenier; Klaas van der Meer
Journal:  BMC Fam Pract       Date:  2012-09-04       Impact factor: 2.497

10.  A test of financial incentives to improve warfarin adherence.

Authors:  Kevin G Volpp; George Loewenstein; Andrea B Troxel; Jalpa Doshi; Maureen Price; Mitchell Laskin; Stephen E Kimmel
Journal:  BMC Health Serv Res       Date:  2008-12-23       Impact factor: 2.655

View more
  23 in total

1.  Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.

Authors:  Melanie Gunawardene; S Willems; B Schäffer; J Moser; R Ö Akbulak; M Jularic; C Eickholt; J Nührich; C Meyer; P Kuklik; S Sehner; V Czerner; B A Hoffmann
Journal:  Clin Res Cardiol       Date:  2016-07-19       Impact factor: 5.460

2.  The effect of placebo adherence on reducing cardiovascular mortality: a meta-analysis.

Authors:  Zhao Yue; Cheng Cai; Yang Ai-Fang; Tang Feng-Min; Chen Li; Wang Bin
Journal:  Clin Res Cardiol       Date:  2013-11-22       Impact factor: 5.460

Review 3.  Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis.

Authors:  Daniel Caldeira; João Costa; Joaquim J Ferreira; Gregory Y H Lip; Fausto J Pinto
Journal:  Clin Res Cardiol       Date:  2015-02-03       Impact factor: 5.460

4.  Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.

Authors:  Steffen Gloekler; Samera Shakir; Janosch Doblies; Ahmed A Khattab; Fabien Praz; Ênio Guerios; Dezsoe Koermendy; Stefan Stortecky; Thomas Pilgrim; Lutz Buellesfeld; Peter Wenaweser; Stephan Windecker; Aris Moschovitis; Milosz Jaguszewski; Ulf Landmesser; Fabian Nietlispach; Bernhard Meier
Journal:  Clin Res Cardiol       Date:  2015-03-04       Impact factor: 5.460

5.  Safety of percutaneous coronary intervention in patients with acute ischemic stroke/transient ischemic attack and acute coronary syndrome.

Authors:  Tobias Zeus; Ulrike Ketterer; Daniela Leuf; Lisa Dannenberg; Florian Bönner; Rabea Wagstaff; Michael Gliem; Sebastian Jander; Malte Kelm; Amin Polzin
Journal:  Clin Res Cardiol       Date:  2015-10-29       Impact factor: 5.460

6.  Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry.

Authors:  Ute Amann; Inge Kirchberger; Margit Heier; Hildegard Golüke; Wolfgang von Scheidt; Bernhard Kuch; Annette Peters; Christa Meisinger
Journal:  Clin Res Cardiol       Date:  2014-03-07       Impact factor: 5.460

7.  A pharmacist checklist for direct oral anticoagulant management: Raising the bar.

Authors:  Kori Leblanc; William M Semchuk; John Papastergiou; Blair Snow; Leilany Mandlsohn; Vinay Kapoor; Lisa M Guirguis; James D Douketis; William Geerts; David J Gladstone
Journal:  Can Pharm J (Ott)       Date:  2018-02-09

8.  Adherence in outpatients taking warfarin and its effect on anticoagulation control in Jordan.

Authors:  Mera A Ababneh; Sayer I Al-Azzam; Karem H Alzoubi; Abeer M Rababa'h
Journal:  Int J Clin Pharm       Date:  2016-03-25

9.  Adherence to warfarin treatment among patients with atrial fibrillation.

Authors:  Mika Skeppholm; Leif Friberg
Journal:  Clin Res Cardiol       Date:  2014-07-31       Impact factor: 5.460

10.  Risk prediction with triglycerides in patients with stable coronary disease on statin treatment.

Authors:  Christian Werner; Anja Filmer; Marco Fritsch; Stephanie Groenewold; Stefan Gräber; Michael Böhm; Ulrich Laufs
Journal:  Clin Res Cardiol       Date:  2014-07-11       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.